Methyiphenidate vs. amphetamine: Comparative review (Q22241805)

Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis

volume

3

0 references

issue

4

0 references

page(s)

200-211

0 references

cites work

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Differential Effect of Amphetamine Optical Isomers on Bender Gestalt Performance of the Minimally Brain Dysfunctioned

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Levoamphetamine and Dextroamphetamine: Differential Effect on Aggression and Hyperkinesis in Children and Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Stimulant drug treatment of hyperactivity: biochemical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Methylphenidate effects on activity-stress gastric lesions and regional brain noradrenaline metabolism in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Provocative tests with psychostimulant drugs in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

[125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Discriminative stimulus properties of amphetamine and other stimulants in lead-exposed and normal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Metaphit prevents locomotor activation induced by various psychostimulants and interferes with the dopaminergic system in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

ADHD in girls: clinical comparability of a research sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

Influence of naloxone upon motor activity induced by psychomotor stimulant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

7 January 2021

Methylphenidate and pemoline do not cause depletion of rat brain monoamine markers similar to that observed with methamphetamine

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

7 January 2021

Effects of chronic amphetamine in BALB/cBy mice, a strain that is not stimulated by acute administration of amphetamine.

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

7 January 2021

A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

7 January 2021

Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

7 January 2021

Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

7 January 2021

Amphetamine, but not methylphenidate, predicts antidepressant response

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

7 January 2021

Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation

1 reference

https://api.crossref.org/works/10.1177%2F108705470000300403

7 January 2021